Publication | Closed Access

Clinical and economic impact of procalcitonin to shorten antimicrobial therapy in septic patients with proven bacterial infection in an intensive care setting

Critical Care ManagementCritical Care MedicineAntibioticsProven Bacterial InfectionHealthcare-associated InfectionPatient SafetyAcute CareSepsisEconomic ImpactInfection ControlMedicineClinical MicrobiologyAntimicrobial Resistance